Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
Title:
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
Author:
Wong, Boaz Bergeron, Anabel Maznyi, Glib Ng, Kristy Jirovec, Anna Birdi, Harsimrat K. Serrano, Daniel Spinelli, Marcus Thomson, Max Taha, Zaid Alwithenani, Akram Chen, Andrew Lorimer, Ian Vanderhyden, Barbara Arulanandam, Rozanne Diallo, Jean-Simon